Biomarkers for Scleroderma GI
Correlation with Other Symptoms
Dysphagia (Difficulty Swallowing)
Esophagus (Throat) Involvement
|Esophagus: Reflux (Heartburn)
GAVE (Watermelon Stomach)
Loss of Appetite
GI involvement consists of a variety of symptoms and conditions that include nausea and vomiting, difficulty with swallowing, constipation, diarrhea, GERD (gastroesophageal reflux disease), problems with digestion, gastroparesis, and watermelon stomach.
Some of these symptoms are bothersome and can have a serious affect on your quality of life. Others are life threatening. All should be taken seriously and discussed with your doctor. (Also see Scleroderma Gastrointestinal Involvement, What is Scleroderma?, Types of Scleroderma, and Systemic Sclerosis
Intestinal Involvement in Systemic Sclerosis (SSc): A Clinical Review. Multidisciplinary approach of intestinal manifestations in SSc by gastroenterologists and rheumatologists is required for optimum management. PubMed, Dig Dis Sci, 2018 Apr;63(4):834-844.
Evaluation and management of esophageal manifestations in systemic sclerosis (SSc). This review summarizes our knowledge concerning the evaluation and management of esophageal manifestations in SSc patients, including emerging therapeutic modalities. PubMed, Ann Gastroenterol, 2018 Mar-Apr;31(2):165-170.
How to beat health problems no one likes to talk about. When it comes to digestive troubles we’re remarkably shy, with more than 40 per cent of people never discussing their symptoms with a doctor. Mail Online, 08/22/2017.
Review article: pathogenesis and clinical manifestations of gastrointestinal involvement (GI) in systemic sclerosis (SSc). The pathogenesis of GI in SSc remains elusive and an improved understanding of novel pathogenic mechanisms may allow the development of potentially highly effective approaches, including intravenous immunoglobulin and microRNA based therapeutic interventions. PubMed, Aliment Pharmacol Ther, 2017 Apr;45(7):883-898.
Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review. Longitudinal observational studies are warranted, as there is insufficient evidence to describe the risk factors for GI problems in patients with scleroderma. PMC, 12/30/2015.
Systemic Sclerosis: Gastrointestinal Disease and Its Management. Recent studies on the pathophysiology of the disease highlight new mechanisms to explain gastrointestinal dysmotility, but treatment remains symptomatic. PubMed, Rheum Dis Clin North Am, 2015 Aug;41(3):459-73.
Study Demonstrates Benefits of Medical Nutrition Therapy (MNT) Intervention in Systemic Sclerosis (SSc) Patients with Gastrointestinal Involvement (GI). Future studies should include direct measures of body composition and should seek to determine the durability of MNT on symptom improvement in a larger number of patients with SSc involving the GI tract. Scleroderma News, 07/27/2015. (Also see Diet and Scleroderma)
Gastrointestinal (GIT) and Hepatic Disease in Systemic Sclerosis (SSc). Proper diagnostics and therapeutics for SSc-GIT involvement require the treating physician to have an understanding of an integrated approach and potential medication adverse effects. PubMed, Rheum Dis Clin North Am, 2018 Feb;44(1):15-28.
Fecal calprotectin in systemic sclerosis and review of the literature. Abnormal fecal calprotectin levels were correlated with gastrointestinal impairment, especially small intestinal bacterial overgrowth (SIBO). Fecal calprotectin (FC) may be a helpful test in identifying the group of systemic sclerosis patients at high risk for SIBO. PubMed, Autoimmun Rev, 2015 Jun;14(6):547-54. (Also see Systemic Sclerosis Prognosis and Mortality: Biomarkers)
Consider GERD in patients with pulmonary diseases. Gastroesophageal reflux disease (GERD) has been linked to many forms of pulmonary disease. However, because not all presentations of lung diseases include GERD’s more commonly recognized symptoms, it may be missed as a contributing factor. American College of Physicians. (Also see Correlation between Pulmonary Fibrosis and other Diseases or Complications)
Sleep disturbances in systemic sclerosis (SSc): evidence for the role of gastrointestinal symptoms, pain and pruritus. Gastrointestinal symptoms, pain and pruritus were associated with sleep disturbance in SSc. Additional research is needed on sleep in SSc so that well-informed sleep interventions can be developed and tested. PubMed, Rheumatology. (Also see Sleep Disorders and Scleroderma, Pain, and Scleroderma Skin Involvement: Itching)
Systemic scleroderma can affect the entire digestive tract, affecting swallowing, digestion, and elimination.
(PDF) The UCLA SCTC GIT 2.0 Questionnaire. This patient questionnaire evaluates gastrointestinal involvement in systemic sclerosis. Patients may complete this questionnaire and take it to their doctors. It is also a valuable tool for evaluating clinical trials. Dinesh Khanna, MD, MSc.
Bowel Involvement. Scleroderma can cause constipation, diarrhea, malabsorption, diminished peristalsis, intestinal pseudo-obstruction, and bowel incontinence. Typical in the initial stages of scleroderma is chronic constipation, sometimes alternating with diarrhea. Late stage scleroderma bowel involvement is often marked by diarrhea, malabsorption, and bowel incontinence. ISN.
Causes of Bowel Dysfunction
|Intestinal Bacterial Overgrowth
Inflammatory Bowel Disease (IBD)
Irritable Bowel Syndrome (IBS)
Dysmotility syndrome refers to muscles in the gastrointestinal tract not working properly. This can include the throat (esophagus), stomach, and bowels. When the stomach is affected, it is often called gastroparesis. When it affects the bowels, it may be called intestinal pseudo-obstruction. ISN. (Also see Esophagus, Gastroparesis, and Bowel Involvement)
Correlation with other Complications
Dysphagia is the medical term for difficulty in swallowing. Symptoms include a sensation of food sticking in the throat, chest pressure or 'burning' after eating, or a feeling of choking. Dysphagia can be due to many different things. Occasionally it is one of the symptoms of systemic scleroderma. ISN.
Liquefied Food for Dysphagia
|Enteral or Parenteral Nutrition (TPN)
Dysphagia Personal Stories
Esophageal (Throat) Involvement. Scleroderma can cause Barrett's Esophagus, esophageal diseases, esophageal stricture, and esophageal ulcers. ISN.
Correlation with Lung Disease
Dysphonia (Hoarseness, Loss of Voice)
|Esophageal Motility Disorders
Gastric MALT Lymphoma
Esophagus: Reflux (Heartburn) and GERD. There are many effective treatments and lifestyle modifications for reflux (heartburn) which is very common in scleroderma patients. ISN.
Cough Due to Heartburn
Heartburn, GERD and Scleroderma
About Reflux (Heartburn)
Reflux and Atrial Fibrillation
Reflux and Lung Involvement
Reflux Prevention and Treatments
What is Gastroparesis? Symptoms, diagnosis, treatments, and support. Gastroparesis and Dysmotilities Association.
Functional Dyspepsia and Gastroparesis. Precise identification of the cause and pathophysiology of upper gastrointestinal symptoms is essential for optimal management. PubMed, Dig Dis, 2016;34(5):491-9.
Jason: Linear Scleroderma I have recently been diagnosed with Raynaud's as well, have had gastrointestinal difficulties more common to systemic forms, and have witnessed these lesions grow and deepen rather than decrease in size…
Jody: Fibromyalgia/Difficult Diagnosis In Sudan, I was on IV for heat stroke and food poisoning. And in Thailand, at the end of March, it all came to a crashing halt…
Sandy J: CREST Scleroderma I have had an ileostomy for two years and a feeding peg for just over one year, and would appreciate comments from any person who also has one or both of these problems…
Tami: Morphea Scleroderma I have gotten used to the stares everyone casts my way because in their eyes I am different. Unique, I guess…
Trish: Spouse of a Diffuse Scleroderma Patient My husband was diagnosed with scleroderma in June of 2000…
A loss of appetite can occur for a great many reasons, including anxiety, depression, infection, medication and treatment side-effects, and many illnesses. There are medications that can stimulate appetite, as well as treat nausea. Loss of appetite in a scleroderma patient may be indicative of gastrointestinal involvement. If appetite loss persists, it is important to consult your medical care provider.
Serum albumin is not useful as a marker for malnutrition in scleroderma.
Intestinal dysbiosis is common in systemic sclerosis (SSc) and associated with gastrointestinal and extraintestinal features of disease. In this cross-sectional study, intestinal dysbiosis was common in patients with SSc and was associated with gastrointestinal dysfunction, malnutrition and with some inflammatory, fibrotic and vascular extraintestinal features of SSc. PubMed, Arthritis Res Ther, 2016 Nov 29;18(1):278. (Also see Diet and Scleroderma)
Case Report: Benign Spontaneous Pneumoperitoneum in Systemic Sclerosis (SSc). We report a case of spontaneous pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity) without evidence of peritoneal irritation in a malnourished patient with long-standing SSc. PubMed, J Clin Rheumatol.
Watermelon Stomach is the popular name for Gastric Antral Vascular Ectasia (GAVE) — a condition in which the lining of the stomach bleeds, causing it to look like the characteristic stripes of a watermelon when viewed by endoscopy. ISN.
|What is Watermelon Stomach?
|A Patient's Perspective
Watermelon Stomach in Associated with Other Diseases
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement (GI) in systemic sclerosis (SSc). Sustained benefit from IVIG suggests a specific immunomodulatory effect on those with established SSc GI complications. PubMed, Rheumatology (Oxford), 08/28/2015. (Also see IVIg)
Nausea and Vomiting Many illnesses can cause stomach pain, nausea and vomiting. Some are mild sicknesses that will pass by themselves, but others are serious and need medical attention. familydoctor.org.
SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses.
We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: